Skip to main content
Smart Investors Daily
LI

NASDAQ · LIPO

Lipella Pharmaceuticals Inc.

Healthcare · Biotechnology

$0.00

Up+$0.00 (+0.00%)

Updated Sep 15, 2026, 8:15 PM

SID Score

4.9/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
1.43M
P/E ratio
-0
Dividend yield
0.00%
52-week range
— – —
Volume
160.09K
Avg. volume
11.25K

Price performance

LIPO price history

1M range · 0 trading sessions · Daily adjusted prices

LIPO does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest LIPO news

The latest Smart Investors Daily articles mentioning LIPO.

LIPO research

Overview

Company profile and research snapshot.

Company profile

LIPELLA PHARMS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$2.00
Implied upside
Analysts
7
LIPO recent ratings
DateFirmRatingTarget
Apr 9, 2024Maxim GroupBuy
Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Nov 26, 2025

Lipella Pharmaceuticals (NASDAQ:LIPO) Trading Down 14.8% – Here’s What Happened

Lipella Pharmaceuticals Inc. (NASDAQ: LIPO - Get Free Report)'s stock price dropped 14.8% on Tuesday. The stock traded as low as $0.3410 and last traded at $0.3410. Approximately 22,645 shares traded hands during trading, a decline of 96% from the average daily volume of 631,420 shares. The stock had previously closed at $0.40. Lipella Pharmaceuticals

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.